Renovis Surgical Announces FDA Clearance of T710 External Fixation System

— Press Release —

Redlands, CA / Austin, TX (May 11, 2011) – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the T710™ Large External Fixation System.

The T710 External Large Fixation System was designed to temporarily stabilize fractures in the hip, femur and tibia. The system offers carbon fiber rods and titanium clamps which may be combined into multiple configurations to address various patient needs. A distinguishing feature of the system is the simple “snap-on” locking mechanism on the clamps, which allows the surgeon to easily assemble what would otherwise be a complex and tedious construct.

External fixation is an important part of the spectrum of care for trauma patients. In many cases, tissue swelling and associated complications make permanent surgery difficult, if not impossible. Temporary solutions like external fixators allow the surgeon to stabilize the patient until swelling subsides and more permanent hardware can be implanted.

About Renovis Surgical
Renovis Surgical Technologies was founded in 2009 with the express mission of creating highest quality implants for orthopedics, spine and trauma, and delivering those implants to the healthcare marketplace at a value. The company is based in Redlands, California, and has engineering and manufacturing operations in Austin, Texas.

For additional information on the Company, please visit renovis-surgical.com.

# # #

Media Contact: 909.557.2360